Similar articles for PMID: 16425095

Year	Number of Results
1962	1
1995	1
1996	3
1998	4
1999	7
2000	5
2001	6
2002	11
2003	10
2004	14
2005	17
2006	21
2007	12
2008	11
2009	10
2010	12
2011	11
2012	12
2013	14
2014	10
2015	4
2016	8
2017	12
2018	8
2019	9
2020	4
2021	6
2022	7
2023	2
2024	0

1

Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).

Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Grönberg H, Bälter KA. Hedelin M, et al. Cancer Causes Control. 2006 Mar;17(2):169-80. doi: 10.1007/s10552-005-0342-2. Cancer Causes Control. 2006. PMID: 16425095

2

Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.

Hedelin M, Bälter KA, Chang ET, Bellocco R, Klint A, Johansson JE, Wiklund F, Thellenberg-Karlsson C, Adami HO, Grönberg H. Hedelin M, et al. Prostate. 2006 Oct 1;66(14):1512-20. doi: 10.1002/pros.20487. Prostate. 2006. PMID: 16921512

3

Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.

Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P. Kilkkinen A, et al. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1209-12. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652283

4

Phyto-oestrogens and risk of prostate cancer in Scottish men.

Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE. Heald CL, et al. Br J Nutr. 2007 Aug;98(2):388-96. doi: 10.1017/S0007114507700703. Epub 2007 Apr 3. Br J Nutr. 2007. PMID: 17403269 Free article.

5

Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.

Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H. Pietinen P, et al. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11319174

6

Plasma enterolactone and genistein and the risk of premenopausal breast cancer.

Piller R, Chang-Claude J, Linseisen J. Piller R, et al. Eur J Cancer Prev. 2006 Jun;15(3):225-32. doi: 10.1097/01.cej.0000197449.56862.75. Eur J Cancer Prev. 2006. PMID: 16679865

7

Adolescent dietary phytoestrogen intake and breast cancer risk (Canada).

Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU. Thanos J, et al. Cancer Causes Control. 2006 Dec;17(10):1253-61. doi: 10.1007/s10552-006-0062-2. Cancer Causes Control. 2006. PMID: 17111256

8

Prospective study of plasma enterolactone and prostate cancer risk (Sweden).

Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H. Stattin P, et al. Cancer Causes Control. 2004 Dec;15(10):1095-102. doi: 10.1007/s10552-004-1480-7. Cancer Causes Control. 2004. PMID: 15801493

9

Plasma enterolactone and breast cancer incidence by estrogen receptor status.

Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A. Olsen A, et al. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2084-9. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598765

10

Urinary phytoestrogens and postmenopausal breast cancer risk.

den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. den Tonkelaar I, et al. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

220 results

Results by year